MedPath

辽宁卫星生物制品研究所(有限公司)

Ownership
-
Established
2001-05-09
Employees
-
Market Cap
-
Website
www.yueho.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Recombinant Human Interferon ɑ2a for Injection

Product Name
迪恩安
Approval Number
国药准字S10980086
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20020008
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interferon ɑ2a for Injection

Product Name
迪恩安
Approval Number
国药准字S10980085
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor Injection

Product Name
注射用重组人粒细胞巨噬细胞刺激因子
Approval Number
国药准字S20030007
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interferon ɑ2a for Injection

Product Name
迪恩安
Approval Number
国药准字S10980104
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20020048
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20020047
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20020049
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20020046
Approval Date
Jun 24, 2020
NMPA

Recombinant Human Interleukin-2(I)for Injection

Product Name
注射用重组人白介素-2(Ⅰ)
Approval Number
国药准字S20053057
Approval Date
Jun 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.